Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein

被引:115
|
作者
Gout, I
Middleton, G
Adu, J
Ninkina, NN
Drobot, LB
Filonenko, V
Matsuka, G
Davies, AM
Waterfield, M
Buchman, VL
机构
[1] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland
[2] Ludwig Inst Canc Res, London W1P 8BT, England
[3] Inst Mol Biol & Genet, UA-252143 Kiev, Ukraine
[4] HV Palladin Inst Biochem, UA-290005 Lvov, Ukraine
[5] Russian Acad Sci, Inst Gene Biol, Moscow, Russia
来源
EMBO JOURNAL | 2000年 / 19卷 / 15期
关键词
adaptor protein; neuronal apoptosis; phosphoinositide; 3-kinase; signal transduction;
D O I
10.1093/emboj/19.15.4015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Class I-A phosphatidylinositol 3-kinase (PI3-kinase) is a key component of important intracellular signalling cascades. We have identified an adaptor protein, Ruk(1), which forms complexes with the PI 3-kinase holoenzyme in vitro and in vivo. This interaction involves the proline-rich region of Ruk and the SH3 domain of the p85 alpha regulatory subunit of the class I-A PI 3-kinase. In contrast to many other adaptor proteins that activate PI 3-kinase, interaction with Ruk(1) substantially inhibits the lipid kinase activity of the enzyme. Overexpression of Ruk(1) in cultured primary neurons induces apoptosis, an effect that could be reversed by co-expression of constitutively activated forms of the p110 alpha a catalytic subunit of PI 3-kinase or its downstream effector PKB/Akt, Our data provide evidence for the existence of a negative regulator of the PI 3-kinase signalling pathway that is essential for maintaining cellular homeostasis. Structural similarities between Ruk, CIN85 and CD2AP/CMS suggest that these proteins form a novel family of adaptor molecules that are involved in various intracellular signalling pathways.
引用
收藏
页码:4015 / 4025
页数:11
相关论文
共 50 条
  • [31] Negative regulation of phosphatidylinositol 3-kinase and Akt signalling pathway by PKC
    Wen, HC
    Huang, WC
    Ali, A
    Woodgett, JR
    Lin, WW
    CELLULAR SIGNALLING, 2003, 15 (01) : 37 - 45
  • [32] Activation of a novel class-II PI 3-kinase by insulin
    Shepherd, PR
    Brown, RA
    DIABETES, 1999, 48 : A330 - A331
  • [33] Phosphatidylinositol 3-kinase (PI3K) signaling and regulation of the antibody response
    Omori, Sidne A.
    Rickert, Robert C.
    CELL CYCLE, 2007, 6 (04) : 397 - 402
  • [34] PI 3-Kinase p110β Regulation of Platelet Integrin αIIbβ3
    Jackson, Shaun P.
    Schoenwaelder, Simone M.
    PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 203 - 224
  • [35] A novel role for phosphatidylinositol 3-kinase: Regulation of the antiviral response
    Moran, JM
    Lents, NH
    Buller, ML
    Corbett, JA
    DIABETES, 2004, 53 : A300 - A300
  • [36] PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of β1-adrenergic preconditioning
    Robinet, A
    Hoizey, G
    Millart, H
    CARDIOVASCULAR RESEARCH, 2005, 66 (03) : 530 - 542
  • [37] PI 3-kinase related kinases as novel targets for anticancer drug discovery
    Abraham, RT
    FASEB JOURNAL, 2003, 17 (05): : A791 - A792
  • [38] Role of phosphoinositide 3-kinase and the Cbl adaptor protein in coupling the α4β1 integrin to mitogen-activated protein kinase signalling
    Finkelstein, LD
    Shimizu, Y
    BIOCHEMICAL JOURNAL, 2000, 345 : 385 - 392
  • [39] Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis
    Funamoto, S
    Meili, R
    Lee, S
    Parry, L
    Firtel, RA
    CELL, 2002, 109 (05) : 611 - 623
  • [40] The role of PI 3-kinase in insulin action
    Alessi, DR
    Downes, CP
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1998, 1436 (1-2): : 151 - 164